-
Je něco špatně v tomto záznamu ?
Antibiofilm activity of bioactive hop compounds humulone, lupulone and xanthohumol toward susceptible and resistant staphylococci
K. Bogdanova, M. Röderova, M. Kolar, K. Langova, M. Dusek, P. Jost, K. Kubelkova, P. Bostik, J. Olsovska,
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- antibakteriální látky farmakologie MeSH
- biofilmy účinky léků MeSH
- buněčné linie MeSH
- cyklohexeny farmakologie MeSH
- flavonoidy farmakologie MeSH
- Humulus chemie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- propiofenony farmakologie MeSH
- rostlinné extrakty farmakologie MeSH
- Staphylococcus účinky léků genetika růst a vývoj MeSH
- terpeny farmakologie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Bacterial biofilms pose a serious medical problem due to their significant resistance to antimicrobials, and staphylococci are recognized as the most frequent cause of biofilm-associated infections. The hop plant (Humulus lupulus L.) contains substances that have been determined to act as anti-infective agents against bacteria, mainly in planktonic form. Therefore, we decided to investigate the antibiofilm properties of H. lupulus L.-derived compounds (humulone, lupulone and xanthohumol) against a selected group of Staphylococcus spp., including methicillin-susceptible and resistant strains. All tested hop compounds were shown to possess antimicrobial properties against all tested staphylococci, both planktonic and biofilm-dwelling, with no significant difference between resistant and susceptible strains. All compounds lowered the number of bacterial cells released from the biofilm, with the strongest effect seen for lupulone, followed by xanthohumol. Moreover, lupulone and xanthohumol were not only able to penetrate the biofilm and reduce the number of bacteria within it, but their higher concentrations (∼60 μg/mL for xanthohumol and ∼125 μg/mL for lupulone) reduced the number of surviving bacterial cells to zero.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033343
- 003
- CZ-PrNML
- 005
- 20181015115406.0
- 007
- ta
- 008
- 181008s2018 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.resmic.2017.12.005 $2 doi
- 035 __
- $a (PubMed)29407045
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Bogdanova, Katerina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc, Czech Republic. Electronic address: katerina.bogdanova@upol.cz.
- 245 10
- $a Antibiofilm activity of bioactive hop compounds humulone, lupulone and xanthohumol toward susceptible and resistant staphylococci / $c K. Bogdanova, M. Röderova, M. Kolar, K. Langova, M. Dusek, P. Jost, K. Kubelkova, P. Bostik, J. Olsovska,
- 520 9_
- $a Bacterial biofilms pose a serious medical problem due to their significant resistance to antimicrobials, and staphylococci are recognized as the most frequent cause of biofilm-associated infections. The hop plant (Humulus lupulus L.) contains substances that have been determined to act as anti-infective agents against bacteria, mainly in planktonic form. Therefore, we decided to investigate the antibiofilm properties of H. lupulus L.-derived compounds (humulone, lupulone and xanthohumol) against a selected group of Staphylococcus spp., including methicillin-susceptible and resistant strains. All tested hop compounds were shown to possess antimicrobial properties against all tested staphylococci, both planktonic and biofilm-dwelling, with no significant difference between resistant and susceptible strains. All compounds lowered the number of bacterial cells released from the biofilm, with the strongest effect seen for lupulone, followed by xanthohumol. Moreover, lupulone and xanthohumol were not only able to penetrate the biofilm and reduce the number of bacteria within it, but their higher concentrations (∼60 μg/mL for xanthohumol and ∼125 μg/mL for lupulone) reduced the number of surviving bacterial cells to zero.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a biofilmy $x účinky léků $7 D018441
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a cyklohexeny $x farmakologie $7 D053138
- 650 _2
- $a flavonoidy $x farmakologie $7 D005419
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Humulus $x chemie $7 D027582
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a rostlinné extrakty $x farmakologie $7 D010936
- 650 _2
- $a propiofenony $x farmakologie $7 D011427
- 650 _2
- $a Staphylococcus $x účinky léků $x genetika $x růst a vývoj $7 D013210
- 650 _2
- $a terpeny $x farmakologie $7 D013729
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Röderova, Magdalena $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc, Czech Republic.
- 700 1_
- $a Kolar, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc, Czech Republic.
- 700 1_
- $a Langova, Katerina $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, Olomouc, Czech Republic.
- 700 1_
- $a Dusek, Martin $u Research Institute of Brewing and Malting, PLC, Lipova 15, Prague, Czech Republic.
- 700 1_
- $a Jost, Petr $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic.
- 700 1_
- $a Kubelkova, Klara $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic.
- 700 1_
- $a Bostik, Pavel $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic.
- 700 1_
- $a Olsovska, Jana $u Research Institute of Brewing and Malting, PLC, Lipova 15, Prague, Czech Republic.
- 773 0_
- $w MED00004095 $t Research in microbiology $x 1769-7123 $g Roč. 169, č. 3 (2018), s. 127-134
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29407045 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181015115902 $b ABA008
- 999 __
- $a ok $b bmc $g 1340112 $s 1030337
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 169 $c 3 $d 127-134 $e 20180131 $i 1769-7123 $m Research in microbiology $n Res Microbiol $x MED00004095
- LZP __
- $a Pubmed-20181008